In KMT2A-rearranged leukemias, the transcriptional consequences of Men1 deletion/Menin/KMT2A inhibition mirror inactivation of the fusion, not inactivation of the KMT2A wild type allele [48]. The gene discussed is KMT2A; the disease is leukemia.